Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 53 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT02830724
- Conditions
- Adenocarcinoma, Adnexal Diseases, Breast Cancer, +41 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
NCT06362369
- Conditions
- ALK Genomic Tumor Aberrations, Adenocarcinoma, Adenoma, +69 more
- Locations
-
- University of Colorado Cancer Center Aurora, Colorado, United States
- Florida Cancer Specialists Lake Mary, Florida, United States
- Dartmouth Hitchcock Lebanon, New Hampshire, United States
- Brown University Health Cancer Institute Providence, Rhode Island, United States
NCT07294859
- Conditions
- AKI - Acute Kidney Injury, Acute Kidney Injury, Adenocarcinoma, +18 more
- Locations
-
- Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University Nanjing, Jiangsu, China
NCT06676527
- Conditions
- Adenocarcinoma, Antineoplastic Agents, Carcinoma, +15 more
- Locations
-
- Jinling Hospital Nanjing, Jiangsu, China
NCT06934057
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
- Locations
-
- Institut de Cancérologie de l'Ouest - Angers Angers, France
- Centre Georges François Leclerc Dijon, France
- Centre Léon Bérard Lyon, France
- Hôpital Tenon Paris, France
NCT05329532
- Conditions
- Adenocarcinoma, Breast Diseases, Breast Neoplasms, +25 more
- Locations
-
- Brighton and Sussex University Hospital Brighton, Default, United Kingdom
- Velindre Cancer Centre Cardiff, Default, United Kingdom
- Edinburgh Cancer Centre (NHS Lothian) Edinburgh, Default, United Kingdom
- Royal Surrey NHS Foundation Guildford, Default, United Kingdom
NCT06903312
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +19 more
- Locations
-
- Fondazione Policlinico Universitario A. Gemelli IRCCS Roma, Italy
NCT06751498
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- The First Affiliated Hospital of Nanjing Medical University (Jiangsu Provincial People's Hospital) Nanjing, Jiangsu, China
- The First Affiliated Hospital of Nanjing Medical University (Jiangsu Provincial People's Hospital) Nanjing, Jiangsu, China
NCT04969315
- Conditions
- Adenocarcinoma, Adnexal Diseases, Bronchial Neoplasms, +52 more
- Locations
-
- USC Norris Comprehensive Cancer Center Los Angeles, California, United States
- Norton Cancer Institute Louisville, Kentucky, United States
- The University of Texas MD Anderson Cancer Center Houston, Texas, United States
NCT06714916
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
- Locations
-
- The First Affiliated Hospital of Nanjing Medical University (Jiangsu Provincial People's Hospital) Nanjing, Jiangsu, China
NCT06745609
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +19 more
- Locations
-
- Department of Urology, Herlev and Gentofte Hospital Herlev, Denmark
NCT06281678
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +42 more
- Locations
-
- University of California, San Francisco (UCSF) San Francisco, California, United States
- Ocala Oncology Center Ocala, Florida, United States
- BRCR Medical Center Plantation, Florida, United States
- University of Kansas Medical Center (KUMC) Fairway, Kansas, United States
NCT04625556
- Conditions
- Adenocarcinoma, Bladder Cancer, Carcinoma, +27 more
- Locations
-
- Yonsei Severance Hospital Seoul, South Korea
NCT04197414
- Conditions
- Adenocarcinoma, Bladder Cancer, Carcinoma, +26 more
- Locations
-
- Department of Urology, Urological Science Institute, Yonsei University, Colleage of Medicine Seoul, South Korea
Not Yet Recruiting
Phase 2 Study of WGI-0301 Plus Nivolumab in Patients With HCC and RCC
NCT07494435
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
- Locations
-
- China Pharmaceutical University, Shanghai Gobroad Cancer Hospital Shanghai, Shanghai Municipality, China
Not Yet Recruiting
Study of the Prognostic Impact of CD44 on Renal Cell Carcinoma
NCT06773377
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
Not specified
NCT03455452
- Conditions
- Adenocarcinoma, Adenocarcinoma Of Kidney, Adenocarcinoma, Renal Cell, +19 more
- Locations
-
- Local Institution - 0001 Paris, France
Completed
A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101)
NCT02684006
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Southern Cancer Center Daphne, Alabama, United States
- Southern Cancer Center Mobile, Alabama, United States
- Southern Cancer Center Mobile, Alabama, United States
- Tower Hematology Oncology Medical Group Beverly Hills, California, United States
NCT06829888
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +18 more
- Locations
-
Not specified
NCT05363072
- Conditions
- Adenocarcinoma, Cancer of Kidney, Cancer of the Kidney, +19 more
- Locations
-
- Pfizer Finland Helsinki, Finland